Here are five quotes from Johnson & Johnson CEO Alex Gorsky on where the company's medical device and healthcare businesses are headed, based on his statement during the fourth quarter 2017 conference call as transcribed by Seeking Alpha:
Spinal Tech
The global neurosurgical products market is anticipated to grow at a 10.5 percent compound annual growth rate through 2023, according to Wise Guy Reports.
Simplify Medical ended a second tranche of its Series B financing.
The SMART Trial finds favorable results for Relievant Medsystems' Intracept Procedure.
Zimmer Biomet is celebrating two decades of its Rapid Recovery program in Europe.
Advertisement
NuVasive named John DeFord, PhD, to its board of directors.
Smith & Nephew's CEO Olivier Bohuon spoke on a range of topics during the company's quarterly earnings call, discussing 2017 results as well as the potential for growth in 2018. In particular, Mr. Bohuon described the company's research and development…
Here are four device company mergers, acquisitions and agreements.
Patients and physicians more than ever are demanding minimally invasive surgery systems that better patient outcomes and reduce operating time.
On Jan. 30, the FDA released two final revised medical device guidance documents entitled "Refuse to Accept Policy for 510(k)s" and "Acceptance and Filing Reviews for Premarket Approval Applications," The National Law Review reports.